BackPTC Therapeutics Overview
PTC Therapeutics Inc

PTC Therapeutics Target Price

Analysts' 12-month price predictions for PTCT.

Get informed when a big investor buys or sells

+ Follow

Share Price

$82.13

Average Target Price

$95.6716.5% upside

3 analysts in the last 4 months

High: $108 | Low: $85

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-27Jefferies$853.5% upsideOpen
2026-05-08Morgan StanleyJudah Frommer$9414.5% upsideOpen
2026-04-10Raymond JamesTiago Fauth$10831.5% upsideOpen
2026-02-23Morgan Stanley$9212% upsideOpen
2026-02-23BarclaysEliana Merle$12046.1% upsideOpen
2026-02-20RBC CapitalBrian Abrahams$820.2% downsideOpen
2026-02-20Wells Fargo$864.7% upsideOpen
2026-01-27Barclays$11944.9% upsideOpen
2026-01-08Morgan Stanley$909.6% upsideOpen
2025-12-01RBC Capital$9110.8% upsideOpen
2025-11-05Goldman Sachs$5039.1% downsideOpen
2025-11-05Wells FargoTiago Fauth$9313.2% upsideOpen
2025-11-05BarclaysGena Wang$6817.2% downsideOpen
2025-10-28JefferiesKelly Shi$776.2% downsideOpen
2025-08-08Robert W. BairdJoel Beatty$7014.8% downsideOpen
2025-05-07Robert W. BairdJoel Beatty$6619.6% downsideOpen
2025-01-07RBC CapitalBrian Abrahams$5829.4% downsideOpen
2024-11-27Robert W. BairdJoel Beatty$5236.7% downsideOpen
2024-10-11Morgan StanleyJeffrey Hung$4545.2% downsideOpen
2024-08-26UBSColin Bristow$4742.8% downsideOpen
2024-07-12Morgan StanleyJeffrey Hung$3261% downsideOpen
2024-05-20Goldman SachsPaul Choi$3261% downsideOpen
2024-05-20JefferiesKelly Shi$4644% downsideOpen
2024-04-26Morgan StanleyJeffrey Hung$3063.5% downsideOpen
2022-12-14Goldman Sachs$3557.4% downsideOpen
2022-06-23RBC CapitalBrian Abrahams$4644% downsideOpen
2022-04-05Cantor FitzgeraldKristen Kluska$6323.3% downsideOpen
2021-08-31UBSColin Bristow$4545.2% downsideOpen